These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24484982)

  • 1. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.
    Matsumoto RR; Nguyen L; Kaushal N; Robson MJ
    Adv Pharmacol; 2014; 69():323-86. PubMed ID: 24484982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
    Nguyen EC; McCracken KA; Liu Y; Pouw B; Matsumoto RR
    Neuropharmacology; 2005 Oct; 49(5):638-45. PubMed ID: 15939443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could sigma receptor ligands be a treatment for methamphetamine addiction?
    Rodvelt KR; Miller DK
    Curr Drug Abuse Rev; 2010 Sep; 3(3):156-62. PubMed ID: 21054260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma-1 receptors: potential targets for the treatment of substance abuse.
    Robson MJ; Noorbakhsh B; Seminerio MJ; Matsumoto RR
    Curr Pharm Des; 2012; 18(7):902-19. PubMed ID: 22288407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
    Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
    Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiological functions of sigma-1 receptors and its relation to psychic dependence].
    Mori T; Yoshizawa K; Shibasaki M; Suzuki T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Dec; 47(6):279-86. PubMed ID: 23461216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma receptors: potential medications development target for anti-cocaine agents.
    Matsumoto RR; Liu Y; Lerner M; Howard EW; Brackett DJ
    Eur J Pharmacol; 2003 May; 469(1-3):1-12. PubMed ID: 12782179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early development of sigma-receptor ligands.
    Narayanan S; Bhat R; Mesangeau C; Poupaert JH; McCurdy CR
    Future Med Chem; 2011 Jan; 3(1):79-94. PubMed ID: 21428827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma Receptors and Substance Use Disorders.
    Sabino V; Hicks C; Cottone P
    Adv Exp Med Biol; 2017; 964():177-199. PubMed ID: 28315272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New synthesis of tic-hydantoins sigma-1 ligands and pharmacological evaluation on cocaine-induced stimulant effects.
    Toussaint M; Debreu-Fontaine MA; Maurice T; Melnyk P
    Med Chem; 2010 Nov; 6(6):355-73. PubMed ID: 20843289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster.
    Highfill CA; Baker BM; Stevens SD; Anholt RRH; Mackay TFC
    PLoS Genet; 2019 May; 15(5):e1007834. PubMed ID: 31107875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.
    Hayashi T; Su TP
    CNS Drugs; 2004; 18(5):269-84. PubMed ID: 15089113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects.
    Toussaint M; Delair B; Foulon C; Lempereur N; Vaccher C; Maurice T; Melnyk P
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):504-15. PubMed ID: 19249191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of sigma receptor ligands on psychiatric disorders].
    Kamei H; Noda Y; Nabeshima T; Yamada K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Oct; 23(5):187-96. PubMed ID: 14653224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma receptors as potential therapeutic targets for neuroprotection.
    Nguyen L; Kaushal N; Robson MJ; Matsumoto RR
    Eur J Pharmacol; 2014 Nov; 743():42-7. PubMed ID: 25261035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials with sigma ligands.
    Volz HP; Stoll KD
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S214-20. PubMed ID: 15547788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.
    Seminerio MJ; Robson MJ; Abdelazeem AH; Mesangeau C; Jamalapuram S; Avery BA; McCurdy CR; Matsumoto RR
    AAPS J; 2012 Mar; 14(1):43-51. PubMed ID: 22183188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies.
    Matsumoto RR; Potelleret FH; Mack A; Pouw B; Zhang Y; Bowen WD
    Pharmacol Biochem Behav; 2004 Apr; 77(4):775-81. PubMed ID: 15099923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.
    Hashimoto K; Ishiwata K
    Curr Pharm Des; 2006; 12(30):3857-76. PubMed ID: 17073684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.